ArticleInternational journal of molecular sciences2019

Regenerative Potential of the Product "CardioCell" Derived from the Wharton's Jelly Mesenchymal Stem Cells for Treating Hindlimb Ischemia.

Aleksandra Musiał-Wysocka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.